Bilateral upper extremity thrombophlebitis related to intravenous amiodarone: a case report.
A 47-year-old male had bilateral upper extremity thrombophlebitis after use of intravenous amiodarone for sustained ventricular tachycardia complicating myocardial infarction. Intravenous amiodarone has been widely used since it was introduced 20 years ago for severe intractable arrhythmias. Superficial thrombophlebitis was frequently noted in the early case reports when high-dose intravenous amiodarone was used. Superficial thrombophlebitis could extend hospitalization and become a significant source of distress to our patients. Some authors recommend insertion of a central line to administer intravenous amiodarone especially with expected extended use of therapy. The treating physician should be vigilant and switch from intravenous therapy to oral therapy as soon as the patient's condition stabilizes and oral therapy can be started.
Aljitawi
Omar
O
Division of Cardiology, Department of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University, and James H. Quillen VA Medical Center, Johnson City, TN, USA. omarj75@aol.com
Shabaneh
Baha
B
Whitaker
Jack
J
D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001132:Arm; D006801:Humans; D007262:Infusions, Intravenous / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000188:drug therapy; D013924:Thrombophlebitis / Q000139:chemically induced*
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone